In the replacement therapy for Type 1 diabetes, researchers from Université Catholique de Louvain (UCL) in Belgium have previously shown that human pancreatic duct-derived cells (HDDCs) are an attractive source of cells. The cells are found in the adult pancreas and are progenitor cells – cells that have a tendency to differentiate into specific types of cells.
In the new study, the group reprogrammed HDDCs to behave like beta cells and secrete insulin within the pancreas, while responding to glucose. The researchers used a specific protein that controls which genes are turned off or on in the genome. This technique allowed them to avoid any potential genetic modification of the target cells.
Share this Post:
ravi
www.keralites.net |
__._,_.___
Posted by: Ravi Narasimhan <ravi.narasimhan.in@gmail.com>
Reply via web post | • | Reply to sender | • | Reply to group | • | Start a New Topic | • | Messages in this topic (1) |
KERALITES - A moderated eGroup exclusively for Keralites...
To subscribe send a mail to Keralites-subscribe@yahoogroups.com.
Send your posts to Keralites@yahoogroups.com.
Send your suggestions to Keralites-owner@yahoogroups.com.
To unsubscribe send a mail to Keralites-unsubscribe@yahoogroups.com.
Homepage: http://www.keralites.net
To subscribe send a mail to Keralites-subscribe@yahoogroups.com.
Send your posts to Keralites@yahoogroups.com.
Send your suggestions to Keralites-owner@yahoogroups.com.
To unsubscribe send a mail to Keralites-unsubscribe@yahoogroups.com.
Homepage: http://www.keralites.net
.
__,_._,___
No comments:
Post a Comment